[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 840
Citations 0
Research Letter
April 9, 2020

e-Cigarette Use Among Young Adult Cancer Survivors Relative to the US Population

Author Affiliations
  • 1Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis
  • 2Division of Hematology, Oncology and Transplantation, Department of Medicine, School of Medicine, University of Minnesota, Minneapolis
  • 3Division of Pediatric Hematology and Oncology, Department of Pediatrics, School of Medicine, University of Minnesota, Minneapolis
  • 4Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Women’s Health, School of Medicine, University of Minnesota, Minneapolis
JAMA Oncol. Published online April 9, 2020. doi:10.1001/jamaoncol.2020.0384

The use of e-cigarettes, known as vaping, has been increasing dramatically among young adults (YAs) relative to other age groups1 and has recently received increased attention because of a rise in vaping-related mortality that is not yet fully understood.2 Young adults with a history of cancer have previously been shown to engage in high-risk health behaviors (eg, smoking) more often than their healthy peers despite greater health risks and their susceptibility to late effects of treatment (eg, subsequent malignant tumors) after cancer.3,4 However, prior research has not evaluated e-cigarette use among YA cancer survivors relative to their peers without cancer.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words